EpiCypher, Tebu-bio Reach European Distribution Agreement | GenomeWeb

NEW YORK (GenomeWeb News) – Epigenetics tools firm EpiCypher today announced it has selected Tebu-bio as its distribution partner in Europe.

Tebu-bio will distribute Research Triangle Park, NC-based EpiCypher's epigenetics and chromatic biology research products. Tebu-bio is based in Le Perray, France and has offices in Belgium, Germany, Italy, the Netherlands, Denmark, Finland, Norway, Sweden, Portugal, Spain, and the UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Feb
23
Sponsored by
NuGEN

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.